Advertisement

In support of synthetic biology, Cambridge-based Gen9 announced it will launch a “G-Prize” contest this fall to develop and foster creative and innovative approaches for using synthetic DNA constructs to advance industries including chemical and enzyme production, biofuels, pharmaceuticals, and even data storage.

Advertisement
Advertisement